Product Information
QUDEXY XR 150 MG CAPSULE is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $29.5236 per EA under NDC 00245107530. Its NADAC has been published 204 times since Jun 21, 2017.
FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245107530
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA205122FDA Approved
3/11/2014
TE Code
AB2
On Market Since
4/11/2014
Pharmacological Classes
Price Statistics
The NADAC for QUDEXY XR 150 MG CAPSULE has been published 204 times since Jun 21, 2017, and over the history we have for it it has risen 59.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29.5236 per EA |
|---|---|
| All-time high | $29.5885 (Feb 12, 2025) |
| All-time low | $18.5039 (Jun 21, 2017) |
| 52-week high | $29.5236 |
| 52-week low | $29.5236 |
| Median price | $24.2207 |
| Average price | $25.0967 |
| Largest weekly change | +22.1% (Nov 20, 2024) |
| Weeks tracked | 204 |
| Tracking since | Jun 21, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
+21.9%
5Y
+21.9%
All
+59.6%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUDEXY XR 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QUDEXY XR 150 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $29.5236 per EA (NDC 00245107530), effective Apr 15, 2026.
How has the price of QUDEXY XR 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QUDEXY XR 150 MG CAPSULE has risen 59.6%. It has been tracked across 204 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for QUDEXY XR 150 MG CAPSULE?
Since Jun 21, 2017, the NADAC for QUDEXY XR 150 MG CAPSULE has ranged from a low of $18.5039 (Jun 21, 2017) to a high of $29.5885 (Feb 12, 2025), with a median of $24.2207 per EA.
Are there cheaper alternatives to QUDEXY XR 150 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 150 MG SPRINK CAP, is $7.5481 per EA — about 74% below QUDEXY XR 150 MG CAPSULE.
Who manufactures QUDEXY XR 150 MG CAPSULE?
QUDEXY XR 150 MG CAPSULE (NDC 00245107530) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.